Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $29.08 USD
Change Today -0.04 / -0.14%
Volume 848.6K
MDCO On Other Exchanges
As of 8:10 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Paul M. Antinori J.D.

Former Senior Vice President, General Counsel and Secretary, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Mr. Paul M. Antinori, J.D., served as Senior Vice President of The Medicines Company from September 2006 to March 3, 2014, served as its General Counsel from May 2002 to March 3, 2014 and also served as its Secretary until March 3, 2014. Mr. Antinori served as Secretary of Targanta Therapeutics Corp. since February 25, 2009. He served as a Vice President of Medicines Co., from August 2004 to August 2006. He served as a General Counsel and a Consultant to Physician Computer ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

Former Secretary and Director


Boston College
University of Virginia School of Law

Other Affiliations*

Annual Compensation*

Total Annual Compensation$427,849

Stock Options*

Restricted Stock Awards$262,469
All Other Compensation$5,148
Exercised Options272,973
Exercised Options Value$2,981,700
Exercisable Options55,152
Exercisable Options Value$1,285,818
Unexercisable Options27,246
Unexercisable Options Value$452,386
Total Value of Options$4,719,904
Total Number of Options355,371

Total Compensation*

Total Annual Cash Compensation$629,808
Total Short Term Compensation$427,849
Other Long Term Compensation$267,617
Total Calculated Compensation$1,004,269
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $29.08 USD -0.04


Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
Pamela Louise Makin MA, Ph.D., MBAChief Executive Officer and Executive Director
BTG plc
1.0M GBP
Peter William Grant Chief Executive Officer and Executive Director
Skyepharma PLC
567.0K GBP
Erik Bogsch Chief Executive Officer, Managing Director, Member of Executive Board and Director
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
Joze Colaric President of Management Board and Chief Executive Officer
KrKa dd Novo Mesto
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at